Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer.
artificial intelligence
cancer
data analysis
machine learning
multi-omics
Journal
Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
11
2021
accepted:
10
01
2022
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
15
2
2022
Statut:
epublish
Résumé
Cancer is defined as a large group of diseases that is associated with abnormal cell growth, uncontrollable cell division, and may tend to impinge on other tissues of the body by different mechanisms through metastasis. What makes cancer so important is that the cancer incidence rate is growing worldwide which can have major health, economic, and even social impacts on both patients and the governments. Thereby, the early cancer prognosis, diagnosis, and treatment can play a crucial role at the front line of combating cancer. The onset and progression of cancer can occur under the influence of complicated mechanisms and some alterations in the level of genome, proteome, transcriptome, metabolome etc. Consequently, the advent of omics science and its broad research branches (such as genomics, proteomics, transcriptomics, metabolomics, and so forth) as revolutionary biological approaches have opened new doors to the comprehensive perception of the cancer landscape. Due to the complexities of the formation and development of cancer, the study of mechanisms underlying cancer has gone beyond just one field of the omics arena. Therefore, making a connection between the resultant data from different branches of omics science and examining them in a multi-omics field can pave the way for facilitating the discovery of novel prognostic, diagnostic, and therapeutic approaches. As the volume and complexity of data from the omics studies in cancer are increasing dramatically, the use of leading-edge technologies such as machine learning can have a promising role in the assessments of cancer research resultant data. Machine learning is categorized as a subset of artificial intelligence which aims to data parsing, classification, and data pattern identification by applying statistical methods and algorithms. This acquired knowledge subsequently allows computers to learn and improve accurate predictions through experiences from data processing. In this context, the application of machine learning, as a novel computational technology offers new opportunities for achieving in-depth knowledge of cancer by analysis of resultant data from multi-omics studies. Therefore, it can be concluded that the use of artificial intelligence technologies such as machine learning can have revolutionary roles in the fight against cancer.
Identifiants
pubmed: 35154283
doi: 10.3389/fgene.2022.824451
pii: 824451
pmc: PMC8829119
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
824451Informations de copyright
Copyright © 2022 Arjmand, Hamidpour, Tayanloo-Beik, Goodarzi, Aghayan, Adibi and Larijani.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer Res Treat. 2016 Apr;48(2):583-95
pubmed: 26323644
Cancers (Basel). 2021 May 21;13(11):
pubmed: 34064004
Int J Mol Sci. 2016 Sep 14;17(9):
pubmed: 27649151
Front Oncol. 2019 Jul 17;9:658
pubmed: 31380288
Nat Commun. 2021 Jun 8;12(1):3445
pubmed: 34103512
Fam Community Health. 2003 Jan-Mar;26(1):64-73
pubmed: 12802129
Genome Biol. 2017 May 5;18(1):83
pubmed: 28476144
Front Biosci (Landmark Ed). 2020 Mar 1;25:1058-1109
pubmed: 32114424
Front Med (Lausanne). 2021 Sep 22;8:747333
pubmed: 34631760
Psychooncology. 2005 Aug;14(8):607-17
pubmed: 15651053
Comput Struct Biotechnol J. 2021 Jan 22;19:949-960
pubmed: 33613862
Insights Imaging. 2020 Aug 12;11(1):91
pubmed: 32785796
Nat Rev Genet. 2016 May;17(5):284-99
pubmed: 26972587
Nano Life. 2010 Mar;1(1n02):
pubmed: 24348868
Front Genet. 2020 Oct 23;11:578345
pubmed: 33193699
Front Oncol. 2020 Oct 14;10:588221
pubmed: 33154949
Sci Rep. 2021 Mar 18;11(1):6265
pubmed: 33737557
BMC Med Res Methodol. 2019 Mar 19;19(1):64
pubmed: 30890124
Integr Cancer Ther. 2014 Jan;13(1):62-7
pubmed: 24105356
Hum Gene Ther. 2021 Nov;32(21-22):1330-1345
pubmed: 33307949
J Can Chiropr Assoc. 2020 Apr;64(1):32-42
pubmed: 32476666
Front Oncol. 2020 Apr 07;10:423
pubmed: 32318338
Front Physiol. 2021 Aug 06;12:705424
pubmed: 34421642
Inform Med Unlocked. 2021;24:100591
pubmed: 33977119
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Curr Opin Genet Dev. 2000 Feb;10(1):81-93
pubmed: 10679386
Cell Metab. 2018 Jan 9;27(1):10-21
pubmed: 29056514
BMJ Health Care Inform. 2020 Jul;27(1):
pubmed: 32675072
Mol Oncol. 2021 Mar;15(3):809-813
pubmed: 33217782
Front Oncol. 2019 Aug 23;9:800
pubmed: 31508364
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Cell Dev Biol. 2021 Jan 21;8:622393
pubmed: 33553159
Curr Oncol Rep. 2018 Nov 13;20(12):93
pubmed: 30421307
Biomolecules. 2021 Apr 12;11(4):
pubmed: 33921457
Int J Mol Cell Med. 2019 Winter;8(Suppl1):30-40
pubmed: 32351907
Expert Rev Mol Diagn. 2015;15(12):1589-603
pubmed: 26565429
Semin Cancer Biol. 2020 Sep 17;:
pubmed: 32950605
IEEE Trans Biomed Eng. 2016 May;63(5):1034-1043
pubmed: 26390440
Cancer Discov. 2019 Jul;9(7):837-851
pubmed: 30992279
Cells. 2019 Apr 01;8(4):
pubmed: 30939818
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419878504
pubmed: 31566009
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):
pubmed: 28049655
Lancet Oncol. 2006 Dec;7(12):1017-26
pubmed: 17138223
J Hematol Oncol. 2020 Dec 7;13(1):170
pubmed: 33287876
Nat Commun. 2018 Aug 28;9(1):3490
pubmed: 30154431
Rep Pract Oncol Radiother. 2011 Jun 08;16(5):170-2
pubmed: 24376975
Ecancermedicalscience. 2019;13:961
pubmed: 31537986
Cancer Manag Res. 2019 Feb 25;11:1829-1841
pubmed: 30881111
Genes (Basel). 2019 Jan 28;10(2):
pubmed: 30696086
Clin Transl Med. 2018 Jul 30;7(1):21
pubmed: 30058036
BMC Med Inform Decis Mak. 2020 Jun 16;20(1):108
pubmed: 32546157
Cancers (Basel). 2019 Aug 07;11(8):
pubmed: 31394729
Am J Cancer Res. 2017 May 01;7(5):1016-1036
pubmed: 28560055
EPMA J. 2018 Apr 11;9(2):175-186
pubmed: 29896316
Comput Struct Biotechnol J. 2021 Jun 22;19:3735-3746
pubmed: 34285775
JAMA Surg. 2018 Jan 17;153(1):e174591
pubmed: 29188298
Front Oncol. 2020 Jun 30;10:1030
pubmed: 32695678
Genome Res. 2013 Jul;23(7):1054-62
pubmed: 23817046
Int J Oncol. 2018 Aug;53(2):725-736
pubmed: 29901113
Cancer Res. 2013 Jan 15;73(2):490-5
pubmed: 23172310
Curr Oncol. 2007 Apr;14(2):45-56
pubmed: 17576465
Front Oncol. 2021 Apr 15;11:652063
pubmed: 33937058
Korean J Anesthesiol. 2013 May;64(5):402-6
pubmed: 23741561
Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S2-S7
pubmed: 27611934
Chin J Cancer. 2013 Nov;32(11):594-603
pubmed: 24206917
Cancers (Basel). 2020 Dec 11;12(12):
pubmed: 33322354
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):2-14
pubmed: 29702206
Indian J Palliat Care. 2015 Jan-Apr;21(1):105-15
pubmed: 25709198
Cancer Cell. 2012 Jul 10;22(1):9-20
pubmed: 22789535
Curr Pharm Des. 2018;24(32):3818-3828
pubmed: 30398105
Mol Oncol. 2010 Dec;4(6):482-95
pubmed: 20937571
Clin Cancer Res. 2018 Mar 15;24(6):1248-1259
pubmed: 28982688
Front Pharmacol. 2013 Jun 25;4:68
pubmed: 23805101
Clin Cancer Res. 2019 Oct 1;25(19):5743-5751
pubmed: 31040150
Hematol Oncol Clin North Am. 2008 Aug;22(4):631-48, viii
pubmed: 18638692
Cell Syst. 2017 Dec 27;5(6):620-627.e3
pubmed: 29153840
J Exp Ther Oncol. 2019 Jan;13(1):71-76
pubmed: 30658031
JCO Clin Cancer Inform. 2020 Sep;4:799-810
pubmed: 32926637
Nat Commun. 2021 May 11;12(1):2700
pubmed: 33976213
Sci Signal. 2020 Sep 08;13(648):
pubmed: 32900881
Int J Mol Sci. 2020 Jan 22;21(3):
pubmed: 31979006
Future Sci OA. 2019 Nov 29;6(2):FSO439
pubmed: 32025328
J Diabetes Metab Disord. 2021 Mar 29;20(1):591-599
pubmed: 34222079
Metabolism. 2017 Apr;69S:S36-S40
pubmed: 28126242
Clin Biochem. 2020 Oct;84:13-20
pubmed: 32589887
Genes (Basel). 2021 Apr 12;12(4):
pubmed: 33921421
Cell Cycle. 2018;17(4):486-491
pubmed: 29251172
Nature. 2003 Jan 23;421(6921):444-8
pubmed: 12540920
Front Oncol. 2021 Aug 06;11:689626
pubmed: 34422643
Cold Spring Harb Perspect Med. 2019 Sep 3;9(9):
pubmed: 30397020
Genes Dev. 2018 Jul 1;32(13-14):868-902
pubmed: 29945886
Cell Physiol Biochem. 2018;51(6):2647-2693
pubmed: 30562755
Adv Cancer Res. 2015;126:1-10
pubmed: 25727144
Comput Biol Chem. 2020 May 12;87:107277
pubmed: 32512487
Cancers (Basel). 2020 Dec 29;13(1):
pubmed: 33383846
J Clin Oncol. 2012 Feb 20;30(6):647-60
pubmed: 22271477
Biomed Res Int. 2018 Oct 3;2018:9836256
pubmed: 30402498
Cancer Res. 2017 Apr 1;77(7):1548-1552
pubmed: 28330928
Nat Commun. 2020 Jul 21;11(1):3475
pubmed: 32694610
J Exp Clin Cancer Res. 2015 Oct 06;34:111
pubmed: 26445347
Am Soc Clin Oncol Educ Book. 2015;:57-65
pubmed: 25993143
Nat Rev Cancer. 2019 Mar;19(3):123-124
pubmed: 30683893
Chirurgia (Bucur). 2017 Jul-Aug;112(4):413-417
pubmed: 28862117
Adv Exp Med Biol. 2021 Nov 05;:
pubmed: 34735713
Am Psychol. 2015 Feb-Mar;70(2):119-33
pubmed: 25730719
Mol Cancer. 2020 Apr 27;19(1):79
pubmed: 32340605
Radiographics. 2021 Oct;41(6):1717-1732
pubmed: 34597235
CA Cancer J Clin. 2021 Jul;71(4):333-358
pubmed: 33982817
Nat Rev Genet. 2019 Aug;20(8):467-484
pubmed: 31068683
J Mol Endocrinol. 2018 Jul 13;:
pubmed: 30006342